[美国临床肿瘤学会/美国病理学家学会关于乳腺癌HER2检测的评论] - Suppr | 超能文献

[Comments on American Society of Clinical Oncology/College of American Pathologists for HER2 testing in breast cancer].

作者信息

Gong Yun, Xiao Chun-hua, Fu Li

机构信息

Department of Pathology, Unversity of Texas M.D. Anderson Cancer Center, Houston, Tx 77030, USA.

出版信息

Zhonghua Bing Li Xue Za Zhi. 2009 Dec;38(12):795-8.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

[Comments on American Society of Clinical Oncology/College of American Pathologists for HER2 testing in breast cancer].[美国临床肿瘤学会/美国病理学家学会关于乳腺癌HER2检测的评论]

Zhonghua Bing Li Xue Za Zhi. 2009 Dec;38(12):795-8.

2

A retrospective population-based comparison of HER2 immunohistochemistry and fluorescence in situ hybridization in breast carcinomas: impact of 2007 American Society of Clinical Oncology/College of American Pathologists criteria.回顾性基于人群的 HER2 免疫组化和荧光原位杂交在乳腺癌中的比较：2007 年美国临床肿瘤学会/美国病理学家学院标准的影响。

Arch Pathol Lab Med. 2014 Feb;138(2):213-9. doi: 10.5858/arpa.2012-0617-OA. Epub 2013 Oct 28.

3

New ASCO/CAP guideline recommendations for HER2 testing increase the proportion of reflex in situ hybridization tests and of HER2 positive breast cancers.美国临床肿瘤学会/美国病理学家学会（ASCO/CAP）关于人表皮生长因子受体2（HER2）检测的新指南建议增加了原位杂交检测及HER2阳性乳腺癌的复检比例。

Virchows Arch. 2016 Feb;468(2):207-11. doi: 10.1007/s00428-015-1871-z. Epub 2015 Oct 31.

4

Laboratory compliance with the American Society of Clinical Oncology/College of American Pathologists human epidermal growth factor receptor 2 testing guidelines: a 3-year comparison of validation procedures.实验室对美国临床肿瘤学会/美国病理学家协会人表皮生长因子受体 2 检测指南的符合情况：验证程序的 3 年比较。

Arch Pathol Lab Med. 2014 Jul;138(7):876-84. doi: 10.5858/arpa.2013-0731-CP.

5

Impact of American Society of Clinical Oncology/College of American Pathologists guideline recommendations on HER2 interpretation in breast cancer.美国临床肿瘤学会/美国病理学家学会指南建议对乳腺癌中HER2检测结果判读的影响

Hum Pathol. 2010 Jan;41(1):103-6. doi: 10.1016/j.humpath.2009.07.001. Epub 2009 Sep 16.

6

[Guidelines for HER2 detection in breast cancer, the 2009 version].

Zhonghua Bing Li Xue Za Zhi. 2009 Dec;38(12):836-40.

7

Impact of the 2013 American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 (HER2) testing of invasive breast carcinoma: a focus on tumours assessed as 'equivocal' for HER2 gene amplification by fluorescence in-situ hybridization.2013年美国临床肿瘤学会/美国病理学家学会关于浸润性乳腺癌人表皮生长因子受体2（HER2）检测的指南建议的影响：聚焦于通过荧光原位杂交评估为HER2基因扩增“不确定”的肿瘤。

Histopathology. 2015 Dec;67(6):880-7. doi: 10.1111/his.12723. Epub 2015 Jun 9.

8

Implications of the Updated 2013 American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations on Human Epidermal Growth Factor Receptor 2 Gene Testing Using Immunohistochemistry and Fluorescence In Situ Hybridization for Breast Cancer.2013年美国临床肿瘤学会/美国病理学家学会关于采用免疫组织化学和荧光原位杂交技术检测乳腺癌人表皮生长因子受体2基因的指南更新建议的影响

Arch Pathol Lab Med. 2016 Feb;140(2):140-7. doi: 10.5858/arpa.2015-0108-OA.

9

ASCO/CAP 2018 breast cancer HER2 testing guidelines: summary of pertinent recommendations for practice in Australia.ASCO/CAP 2018 乳腺癌 HER2 检测指南：澳大利亚临床实践相关推荐要点总结。

Pathology. 2019 Jun;51(4):345-348. doi: 10.1016/j.pathol.2019.02.004. Epub 2019 May 7.

10

Current HER2 Testing Recommendations and Clinical Relevance as a Predictor of Response to Targeted Therapy.当前HER2检测建议及其作为靶向治疗反应预测指标的临床相关性。

Clin Breast Cancer. 2015 Jun;15(3):171-80. doi: 10.1016/j.clbc.2014.11.009. Epub 2014 Dec 2.